Jotaro Sato

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

Shirish M. Gadgeel, Leena Gandhi, Gregory J. Riely et al. · The Lancet Oncology · 2014 · 688 citations

Phase 1/2, Neuro-oncology, Dose-finding Portion +9

<i>yellow</i> and <i>ebony</i> Are the Responsible Genes for the Larval Color Mutants of the Silkworm <i>Bombyx mori</i>

Ryo Futahashi, Jotaro Sato, Yan Meng et al. · Genetics · 2008 · 149 citations · Full text

Bombyx Linkage Map, Genetics, Molecular Genetics +19

EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients

Kathleen M. Hill Gallant, Elizabeth R. Stremke, Laurie L. Trevino et al. · Kidney International · 2020 · 41 citations · Full text

Hemodialysis, Urology, Renal Function +9